← Browse by Condition
Medical Condition
blastic plasmacytoid dendritic cell neoplasm
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1
NCT03779854 Phase 2
Recruiting
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Enrollment
68 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT03113643 Phase 1
Recruiting
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Enrollment
72 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute